Goldman Sachs
SLS icon

Goldman Sachs’s SELLAS Life Sciences SLS Stock Holding History

Goldman Sachs’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-59
Closed -$23K – 6353
2017
Q4 		$23K Hold
59
– – ﹤0.01% 6096
2017
Q3 		$31K Hold
59
– – ﹤0.01% 6359
2017
Q2 		$52K Hold
59
– – ﹤0.01% 6353
2017
Q1 		$54K Sell
59
-32
-35% -$53K ﹤0.01% 6265
2016
Q4 		$264K Buy
+91
New +$529K ﹤0.01% 5577

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Goldman Sachs's SLS Position: Q2 2026 in Review

Goldman Sachs increased its SELLAS Life Sciences (SLS) stake by 5.2% in Q2 2026, buying an estimated $201K and bringing the position to 585,035 shares worth $8.64M. The position accounts for ﹤0.01% of the portfolio, ranked #3378.

Goldman Sachs first reported a position in SLS in Q4 2016 and has held it in 11 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Goldman Sachs held 585,035 shares of SELLAS Life Sciences worth $8.64M as of Q2 2026.
  • Goldman Sachs bought 29,122 SELLAS Life Sciences shares in Q2 2026, an estimated $201K.
  • SELLAS Life Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3378 holding.
  • Goldman Sachs first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 11 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.